136 related articles for article (PubMed ID: 21734230)
1. The Cox-2 -1195 G > A polymorphism and cancer risk: a meta-analysis of 25 case-control studies.
Tang Z; Nie ZL; Pan Y; Zhang L; Gao L; Zhang Q; Qu L; He B; Song G; Zhang Y; Shukui Wang
Mutagenesis; 2011 Nov; 26(6):729-34. PubMed ID: 21734230
[TBL] [Abstract][Full Text] [Related]
2. Potentially functional COX-2-1195G>A polymorphism increases the risk of digestive system cancers: a meta-analysis.
Dong J; Dai J; Zhang M; Hu Z; Shen H
J Gastroenterol Hepatol; 2010 Jun; 25(6):1042-50. PubMed ID: 20594217
[TBL] [Abstract][Full Text] [Related]
3. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.
Wang J; Ding Q; Shi Y; Cao Q; Qin C; Zhu J; Chen J; Yin C
Mutagenesis; 2012 May; 27(3):305-12. PubMed ID: 22058059
[TBL] [Abstract][Full Text] [Related]
4. The CXCL12 G801A polymorphism and cancer risk: evidence from 17 case-control studies.
Gong H; Tan M; Wang Y; Shen B; Liu Z; Zhang F; Liu Y; Qiu J; Bao E; Fan Y
Gene; 2012 Nov; 509(2):228-31. PubMed ID: 22939870
[TBL] [Abstract][Full Text] [Related]
5. Current evidence on the relationship between polymorphisms in the COX-2 gene and breast cancer risk: a meta-analysis.
Yu KD; Chen AX; Yang C; Qiu LX; Fan L; Xu WH; Shao ZM
Breast Cancer Res Treat; 2010 Jul; 122(1):251-7. PubMed ID: 20033767
[TBL] [Abstract][Full Text] [Related]
6. Platelet 12-lipoxygenase Arg261Gln polymorphism: functional characterization and association with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms.
Guo Y; Zhang X; Tan W; Miao X; Sun T; Zhao D; Lin D
Pharmacogenet Genomics; 2007 Mar; 17(3):197-205. PubMed ID: 17460548
[TBL] [Abstract][Full Text] [Related]
7. The DNA repair gene APE1 T1349G polymorphism and cancer risk: a meta-analysis of 27 case-control studies.
Gu D; Wang M; Wang M; Zhang Z; Chen J
Mutagenesis; 2009 Nov; 24(6):507-12. PubMed ID: 19762350
[TBL] [Abstract][Full Text] [Related]
8. FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies.
Zhang Z; Xue H; Gong W; Wang M; Yuan L; Han S; Zhang Z
Carcinogenesis; 2009 Mar; 30(3):487-93. PubMed ID: 19168581
[TBL] [Abstract][Full Text] [Related]
9. Tumour necrosis factor alpha -308G/A polymorphism and risk of the four most frequent cancers: a meta-analysis.
Wang J; Cao C; Luo H; Xiong S; Xu Y; Xiong W
Int J Immunogenet; 2011 Aug; 38(4):311-20. PubMed ID: 21624061
[TBL] [Abstract][Full Text] [Related]
10. The MPO -463G>A polymorphism and cancer risk: a meta-analysis based on 43 case-control studies.
Chu H; Wang M; Wang M; Gu D; Wu D; Zhang Z; Tang J; Zhang Z
Mutagenesis; 2010 Jul; 25(4):389-95. PubMed ID: 20418356
[TBL] [Abstract][Full Text] [Related]
11. P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case-control studies.
Zhang Z; Wang M; Wu D; Wang M; Tong N; Tian Y; Zhang Z
Breast Cancer Res Treat; 2010 Apr; 120(2):509-17. PubMed ID: 19629678
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 1 beta (IL1B) promoter polymorphism and cancer risk: evidence from 47 published studies.
He B; Zhang Y; Pan Y; Xu Y; Gu L; Chen L; Wang S
Mutagenesis; 2011 Sep; 26(5):637-42. PubMed ID: 21653279
[TBL] [Abstract][Full Text] [Related]
13. -765G>C and 8473T>C polymorphisms of COX-2 and cancer risk: a meta-analysis based on 33 case-control studies.
Zhu W; Wei BB; Shan X; Liu P
Mol Biol Rep; 2010 Jan; 37(1):277-88. PubMed ID: 19669667
[TBL] [Abstract][Full Text] [Related]
14. The association between common genetic variant of microRNA-146a and cancer susceptibility.
Qiu LX; He J; Wang MY; Zhang RX; Shi TY; Zhu ML; Mao C; Sun S; Lv FF; Zheng CL; Zhu XD
Cytokine; 2011 Dec; 56(3):695-8. PubMed ID: 21978540
[TBL] [Abstract][Full Text] [Related]
15. COX-2 polymorphisms and colorectal cancer risk: a strategy for chemoprevention.
Pereira C; Pimentel-Nunes P; Brandão C; Moreira-Dias L; Medeiros R; Dinis-Ribeiro M
Eur J Gastroenterol Hepatol; 2010 May; 22(5):607-13. PubMed ID: 20075740
[TBL] [Abstract][Full Text] [Related]
16. No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: evidence from a literature-based meta-analysis.
Yu KD; Chen AX; Shao ZM
Breast Cancer Res Treat; 2010 Aug; 122(3):853-8. PubMed ID: 20076999
[TBL] [Abstract][Full Text] [Related]
17. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer.
Zhang X; Miao X; Tan W; Ning B; Liu Z; Hong Y; Song W; Guo Y; Zhang X; Shen Y; Qiang B; Kadlubar FF; Lin D
Gastroenterology; 2005 Aug; 129(2):565-76. PubMed ID: 16083713
[TBL] [Abstract][Full Text] [Related]
18. Endothelial nitric oxide synthase (eNOS) 894 G>T polymorphism is associated with breast cancer risk: a meta-analysis.
Hao Y; Montiel R; Huang Y
Breast Cancer Res Treat; 2010 Dec; 124(3):809-13. PubMed ID: 20428939
[TBL] [Abstract][Full Text] [Related]
19. The hOGG1 Ser326Cys polymorphism contributes to cancer susceptibility: evidence from 83 case-control studies.
Wang W; Wang M; Chen Y; Zhang Z; Wang S; Xu M; Wang B; Zhao Q; Zhang Z
Mutagenesis; 2012 May; 27(3):329-36. PubMed ID: 22121210
[TBL] [Abstract][Full Text] [Related]
20. [Genetic polymorphisms in the promoter region of cyclooxygenase-2 and their association with risk of gastric cancer].
Zhang XM; Miao XP; Tan W; Sun T; Guo YL; Zhao D; Lin DX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):119-23. PubMed ID: 16733888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
